Literature DB >> 3489806

A recombinant murine granulocyte/macrophage (GM) colony-stimulating factor derived from an inducer T cell line (IH5.5). Functional restriction to GM progenitor cells.

S Kajigaya, T Suda, J Suda, M Saito, Y Miura, M Iizuka, S Kobayashi, N Minato, T Sudo.   

Abstract

The cDNA for the murine granulocyte/macrophage colony-stimulating factor (GM-CSF) was cloned from a cDNA library obtained from a murine T cell line, IH5.5, by using two synthetic probes that encoded two parts of the GM-CSF from murine lung. The cDNA inserted into the plasmid vector pcDV1 was transfected into monkey COS-1 cells and the conditioned medium was used to investigate the hemopoietic activities of the resultant product, recombinant GM-CSF (rGM-CSF), by means of various colony assays. rGM-CSF stimulated only neutrophil/macrophage colonies in the cultures of murine normal bone marrow and fetal liver cells. No other colony stimulating activities (CSA) were seen in the preparation including burst-promoting activity, eosinophil-CSA, megakaryocyte-CSA and mast cell-CSA. rGM-CSF could not support colony formation of 5-fluorouracil-treated mouse spleen cells, in which only the primitive population of stem cells survived. However, after culture of these cells with PWM-spleen cell-conditioned medium (PWM-SCM), the colonies consisting of blast cells were formed. These blast cells could now be induced to form neutrophil/macrophage colonies in the presence of rGM-CSF. Pure neutrophil colonies, pure macrophage colonies, as well as mixed neutrophil/macrophage colonies, were formed from these single blast cells in the presence of rGM-CSF by micromanipulation. rGM-CSF did not act on pluripotent hemopoietic stem cells, but did act directly and selectively on neutrophil/macrophage progenitors. Moreover, striking heterogeneities were noted in the size of the colonies and the proportion of components. GM-CSF is, therefore, considered to play a noninstructive role in the differentiation of the GM pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489806      PMCID: PMC2188406          DOI: 10.1084/jem.164.4.1102

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Purified interleukin-3 and erythropoietin support the terminal differentiation of hemopoietic progenitors in serum-free culture.

Authors:  J Suda; T Suda; K Kubota; J N Ihle; M Saito; Y Miura
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  A new approach to the morphological and cytochemical evaluation of human bone marrow CFUC in agar cultures.

Authors:  G Konwalinka; P Glaser; R Odavic; E Bogusch; F Schmalzl; H Braunsteiner
Journal:  Exp Hematol       Date:  1980-04       Impact factor: 3.084

4.  Molecular cloning of cDNA for murine interleukin-3.

Authors:  M C Fung; A J Hapel; S Ymer; D R Cohen; R M Johnson; H D Campbell; I G Young
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

5.  An improved plasma culture system for the production of megakaryocyte colonies in vitro.

Authors:  H Mizoguchi; K Kubota; Y Miura; F Takaku
Journal:  Exp Hematol       Date:  1979-08       Impact factor: 3.084

6.  Morphological examinations of murine granulocyte/macrophage colonies grown in serum-free cultures.

Authors:  K Kubota; K Motoyoshi; S Kajigaya; T Suda; M Saito; Y Miura
Journal:  Exp Hematol       Date:  1983-05       Impact factor: 3.084

7.  Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.

Authors:  J N Ihle; J Keller; S Oroszlan; L E Henderson; T D Copeland; F Fitch; M B Prystowsky; E Goldwasser; J W Schrader; E Palaszynski; M Dy; B Lebel
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

8.  Proliferative kinetics and differentiation of murine blast cell colonies in culture: evidence for variable G0 periods and constant doubling rates of early pluripotent hemopoietic progenitors.

Authors:  T Suda; J Suda; M Ogawa
Journal:  J Cell Physiol       Date:  1983-12       Impact factor: 6.384

9.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  8 in total

1.  Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice.

Authors:  H Yasuda; Y Ajiki; T Shimozato; M Kasahara; H Kawada; M Iwata; K Shimizu
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Authors:  H E Broxmeyer; D E Williams; S Cooper; R K Shadduck; S Gillis; A Waheed; D L Urdal; D C Bicknell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

3.  Establishment of an interleukin-5-dependent subclone from an interleukin-3-dependent murine hemopoietic progenitor cell line, LyD9, and its malignant transformation by autocrine secretion of interleukin-5.

Authors:  K Tohyama; K H Lee; K Tashiro; T Kinashi; T Honjo
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

4.  Generation of continuous large granular lymphocyte lines by interleukin 2 from the spleen cells of mice infected with Moloney leukemia virus. Involvement of interleukin 3.

Authors:  M Hattori; T Sudo; M Iizuka; S Kobayashi; S Nishio; S Kano; N Minato
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

5.  Identification of proliferating dendritic cell precursors in mouse blood.

Authors:  K Inaba; R M Steinman; M W Pack; H Aya; M Inaba; T Sudo; S Wolpe; G Schuler
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

6.  Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9.

Authors:  K H Lee; T Kinashi; K Tohyama; K Tashiro; N Funato; K Hama; T Honjo
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

7.  Differentiation in vitro of T3+ large granular lymphocytes with characteristic cytotoxic activity from an isolated hematopoietic progenitor colony.

Authors:  N Minato; M Hattori; T Sudo; S Kano; Y Miura; J Suda; T Suda
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

8.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.

Authors:  Y Yamaguchi; T Suda; J Suda; M Eguchi; Y Miura; N Harada; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.